Kawashima Junichi, Ohno Shino, Sakurada Tomoya, Takabayashi Hidehiko, Kudo Mitsuko, Ro Shoki, Kato Shingo, Yakabi Koji
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda Tsujido-Machi, Kawagoe, Saitama 350-8550, Japan.
J Gastroenterol. 2009;44(10):1046-54. doi: 10.1007/s00535-009-0120-0. Epub 2009 Aug 22.
We attempted to clarify the significance of atrophic change of gastric mucosa for reduction of plasma ghrelin concentration irrespective of Helicobacter pylori (Hp) infection.
Plasma acylated (acyl-)ghrelin concentration in 220 subjects, both with and without atrophic gastritis, was measured with an enzyme immunoassay kit. The extent of atrophic change of gastric mucosa was assessed and graded endoscopically. Hp infection was determined by assay of the anti-Hp antibody with an ELISA assay kit.
Plasma acyl-ghrelin concentration was significantly lower in the Hp positive than the Hp negative group, and Hp eradication significantly increased plasma acyl-ghrelin concentrations in Hp positive subjects. Plasma acyl-ghrelin was significantly lower in subjects with severely atrophic gastritis than in those with mild or moderate atrophic gastritis, irrespective of Hp infection or age group (<60 years old or > or = 60 years old). In male subjects with a normal body mass index, plasma acyl-ghrelin concentrations in subjects with severely atrophic gastritis were significantly lower than those in subjects with mildly or moderately atrophic gastritis, suggesting that the results of the study are independent of emaciation or obesity. Logistic regression analysis showed that gastric atrophy is the key factor that modulates plasma acyl-ghrelin levels.
The results suggest that plasma acyl-ghrelin concentration decreases in accordance with the extent of atrophic change in gastric mucosa irrespective of Hp infection, indicating that the low plasma acyl-ghrelin level of subjects with Hp infection is mainly caused by the progress of atrophic changes in gastric mucosa.
我们试图阐明胃黏膜萎缩性改变对降低血浆胃饥饿素浓度的意义,而不考虑幽门螺杆菌(Hp)感染情况。
使用酶免疫分析试剂盒测量220名患有和未患有萎缩性胃炎的受试者血浆酰基化(酰基-)胃饥饿素浓度。通过内镜评估胃黏膜萎缩性改变的程度并进行分级。使用酶联免疫吸附测定试剂盒通过检测抗Hp抗体来确定Hp感染情况。
Hp阳性组的血浆酰基-胃饥饿素浓度显著低于Hp阴性组,且根除Hp可显著提高Hp阳性受试者的血浆酰基-胃饥饿素浓度。无论Hp感染情况或年龄组(<60岁或≥60岁)如何,重度萎缩性胃炎患者的血浆酰基-胃饥饿素均显著低于轻度或中度萎缩性胃炎患者。在体重指数正常的男性受试者中,重度萎缩性胃炎患者的血浆酰基-胃饥饿素浓度显著低于轻度或中度萎缩性胃炎患者,这表明研究结果与消瘦或肥胖无关。逻辑回归分析表明胃萎缩是调节血浆酰基-胃饥饿素水平的关键因素。
结果表明,无论Hp感染情况如何,血浆酰基-胃饥饿素浓度均随胃黏膜萎缩性改变程度而降低,这表明Hp感染患者血浆酰基-胃饥饿素水平低主要是由胃黏膜萎缩性改变的进展所致。